Trio-Tech International

Trio-Tech is a $52 million company that did $36 million of annual revenue and only $1 million of long-term debt.

If you own TRT, you own a tiny chip-testing company trying to turn one hot quarter into a real business.

trt

technology · semiconductors small cap updated feb 6, 2026
$5.90
market cap ~$52M · 52-week range $2–$8
xvary composite: 32 / 100 · weak
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Trio-Tech tests chips, builds test gear, sells related equipment, and owns some property on the side.
how it gets paid
Last year Trio-Tech International made $36M in revenue.
why growth slowed
Revenue fell 13.8% last year. Revenue at $31M mattered most because it nearly equaled the prior year's $36M annual total.
what just happened
The quarter was all about revenue hitting $31M, a number that almost matched the prior year's full-year sales.
At a glance
C++ balance sheet — some cracks in the foundation
35/100 earnings predictability — expect surprises
3.4% return on capital — nothing to write home about
-$0.01 fy2025 eps est
$37M fy2025 rev est
xvary composite: 32/100 — weak
What they do
Trio-Tech tests chips, builds test gear, sells related equipment, and owns some property on the side.
If your chips need bake, shock, vibration, and electrical tests, you do not want to juggle five vendors across Asia and the U.S. Trio-Tech has 673 employees and operations in the United States, Singapore, Malaysia, and Thailand, so you can buy testing, equipment, and distribution from one shop. That matters because the latest quarter hit $31 million of revenue, almost matching the prior year's $36 million, which says customers already inside the network can ramp fast.
semiconductors microcap testing-services semicap-equipment asia-footprint
How they make money
$36M annual revenue · revenue declined -13.8% last year
total revenue
$36M
13.8%
The products that matter
chip reliability testing
Reliability Testing Services
$22M · about 61% of revenue
This is the center of the story. It generated about $22M of the company’s $37M revenue base, and Q2 FY2026 revenue rose 82% from a year earlier.
growth engine
burn-in and test equipment
Test Equipment Manufacturing
$9M · about 25% of revenue
This $9M segment makes the hardware used in semiconductor testing. It matters because it gives Trio-Tech exposure to customer capex, but the growth here is flat.
capex exposed
industrial electronics work
Industrial Electronics
$5M · about 14% of revenue
At roughly $5M, this is the smallest segment. It adds diversification, but not enough to change the investment case on its own.
small contributor
Key numbers
$31M
latest quarter revenue
That is the number to watch because one quarter nearly matched the prior year's $36M annual revenue, which is either a step-change or a mirage.
7.9%
operating margin
Operating margin means money left after running the business. Plain English: TRT keeps less than $0.08 from each $1 of sales before interest and tax.
3.4%
return on capital
Return on capital means profit earned on the money tied up in the business. So what: TRT is not squeezing much out of its assets yet.
$1M
long-term debt
Debt is low at just 2% of capital, which gives TRT more breathing room than you would expect from a $52M microcap.
Financial health
C++
strength
  • balance sheet grade C++ — below average — limited financial resources
  • risk rank 5 — safer than 5% of stocks
  • price stability 10 / 100
  • long-term debt $1M (2% of capital)
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market

Return history isn't available for TRT right now.

source: institutional data · return history unavailable
What just happened
beat estimates
The quarter was all about revenue hitting $31M, a number that almost matched the prior year's full-year sales.
Latest quarter revenue rose 99% vs. prior year and EPS doubled to $0.02. Management also tied demand to AI and EV chip testing in recent coverage, which explains why investors suddenly care.
$31M
revenue
$0.02
eps
16.3%
gross margin
the number that mattered
Revenue at $31M mattered most because it nearly equaled the prior year's $36M annual total, which is the clearest proof that demand changed fast.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

The #1 risk is chip-testing demand rolling over after a single hot quarter.

med
Cyclical demand can giveth and taketh away
The headline growth number is 82%, but the full-year revenue line still fell 13.7% to $37M. That is what a cyclical micro-cap looks like. One surge in AI and EV testing does not make demand durable.
If testing orders cool, the recent revenue spike can fade quickly because the company does not have enough scale elsewhere to offset it.
med
Margins leave almost no room for error
Gross margin is 16.3% and net margin is -0.33%. Trio-Tech reported a small profit in the latest quarter, but the annual numbers still say this business lives near breakeven.
A few points of pricing pressure, underutilization, or cost creep can push earnings back below zero fast.
med
There is no moat if larger test players want the work
Return on capital is 3.4%, which is a polite way of saying the business has not shown special economics. Trio-Tech competes in a capital-intensive niche where bigger operators can matter more.
If demand stays strong but competitors price more aggressively, TRT may win revenue without winning profit.
med
Micro-cap trading cuts both ways
The stock ran 45% since November, but the whole company is still worth about $52M and trades in a $2–$8 52-week range. Small floats create sharp moves in both directions.
You can be right on the business and still get a violent stock move if liquidity dries up or sentiment flips.
The risk picture is simple: a $37M revenue company with near-zero earnings is being asked to prove that one strong demand pocket can become a repeatable business.
source: institutional data · regulatory filings · risk analysis
Pay attention to
the number that mattered
Does revenue stay above the new level
Q2 FY2026 hit $10.3M. If the next quarter falls back hard, you learned the 82% jump was a spike, not a step-change.
calendar
Q3 FY2026 earnings
You need a second data point. Micro-caps can look transformed for one quarter and ordinary again the next.
trend
Repeat burn-in orders
The March 2026 production burn-in order matters because it suggests real customer demand. More announcements would make the growth story less fragile.
risk
Profitability holding above breakeven
The latest quarter showed a small profit. With a 16.3% gross margin and -0.33% annual net margin, that needs to become a pattern, not an exception.
Analyst rankings
earnings predictability
35 / 100
This score says quarterly numbers can swing around. In human-speak, analysts do not trust this business to deliver smooth results.
balance sheet grade
C++
Below average balance-sheet quality. Low debt helps, but the operating profile is still fragile because profits are thin.
source: institutional data
Institutional activity

institutional ownership data for TRT is being compiled.

source: institutional data
Price targets
3-5 year target range
n/a n/a
$6 current price
n/a target midpoint · n/a from current
target data not available

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
TRT
xvary deep dive
trt
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it